EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Chronic N ‐acetyl cysteine treatment does not improve respiratory system performance in the mdx mouse model of Duchenne muscular dystrophy

Michael N Maxwell iD, Anthony L Marullo iD, Esther Valverde-Pérez, Aoife D Slyne, Ben T Murphy iD, Ken D O'Halloran iD

Experimental Physiology · 2024

DOI: 10.1113/ep091862 ↗

At a glance

Journal article in Experimental Physiology, 2024. Written by Michael N Maxwell and 5 co-authors. Institution: Department of Physiology, University College Cork, Cork, Ireland. Major MEDLINE topics: Acetylcysteine, Mice, Inbred mdx, Muscular Dystrophy, Duchenne, Disease Models, Animal. Cited 2 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: Science Foundation Ireland.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Duchenne muscular dystrophy (DMD) is characterised by respiratory muscle injury, inflammation, fibrosis and weakness, ultimately culminating in respiratory failure. The dystrophin‐deficient mouse model of DMD ( mdx ) shows evidence of respiratory muscle remodelling and dysfunction contributing to impaired respiratory system performance. The antioxidant N ‐acetylcysteine (NAC) has been shown to exert anti‐inflammatory and anti‐fibrotic effects leading to improved respiratory muscle performance in a range of animal models of muscle dysfunction, including mdx mice, following short‐term administration (2 weeks). We sought to build on previous work by exploring the effects of chronic NAC administration (3 months) on respiratory system performance in mdx mice. One‐month‐old male mdx mice were randomised to receive normal drinking water ( n = 30) or 1% NAC in the drinking water ( n = 30) for 3 months. At 4 months of age, we assessed breathing in conscious mice by plethysmography followed by ex vivo assessment of diaphragm force‐generating capacity. Additionally, diaphragm histology was performed. In separate studies, in anaesthetised mice, respiratory electromyogram (EMG) activity and inspiratory pressure across a range of behaviours were determined, including assessment of peak inspiratory pressure‐generating capacity. NAC treatment did not affect force‐generating capacity of the mdx diaphragm. Collagen content and immune cell infiltration were unchanged in mdx + NAC compared with mdx diaphragms. Additionally, there was no significant effect of NAC on breathing, ventilatory responsiveness, inspiratory EMG activity or inspiratory pressure across the range of behaviours from basal conditions to peak system performance. We conclude that chronic NAC treatment has no apparent beneficial effects on respiratory system performance in the mdx mouse model of DMD suggesting limited potential of NAC treatment alone for human DMD.

Subjects

MeSH terms (MEDLINE)

AcetylcysteineMice, Inbred mdxMuscular Dystrophy, DuchenneDisease Models, AnimalDiaphragmAnimalsMaleMiceMice, Inbred C57BLRespiratory MusclesRespirationAntioxidantsRespiratory System

Author keywords

antioxidantdiaphragminspiratory pressuremuscular dystrophyrespiratory EMGs

Substances

AcetylcysteineAntioxidants

Authors and institutions

  • Department of Physiology, University College Cork, Cork, Ireland.
  • Departamento de Bioquímica y Biología Molecular y Fisiología, Facultad de Medicina, Universidad de Valladolid, Valladolid, Spain.
  • Unidad de Excelencia Instituto Biomedicina y Genética Molecular (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.

ORCID profiles: Michael N Maxwell, Anthony L Marullo, Ben T Murphy, Ken D O'Halloran

Funding

  • Science Foundation Ireland

Cite

APA

Maxwell, M. N., Marullo, A. L., Valverde-Pérez, E., Slyne, A. D., Murphy, B. T., & O'Halloran, K. D. (2024). Chronic N ‐acetyl cysteine treatment does not improve respiratory system performance in the mdx mouse model of Duchenne muscular dystrophy. Experimental Physiology. https://doi.org/10.1113/ep091862

Vancouver

Maxwell MN, Marullo AL, Valverde-Pérez E, Slyne AD, Murphy BT, O'Halloran KD. Chronic N ‐acetyl cysteine treatment does not improve respiratory system performance in the mdx mouse model of Duchenne muscular dystrophy. Experimental Physiology. 2024. doi:10.1113/ep091862

BibTeX
@article{Maxwell2024,
  author = {Maxwell, Michael N and Marullo, Anthony L and Valverde-Pérez, Esther and Slyne, Aoife D and Murphy, Ben T and O'Halloran, Ken D},
  title = {Chronic N ‐acetyl cysteine treatment does not improve respiratory system performance in the mdx mouse model of Duchenne muscular dystrophy},
  journal = {Experimental Physiology},
  year = {2024},
  doi = {10.1113/ep091862}
}
Start for free →